Our core belief is that no single technology will answer all diagnostic research questions that we encounter. We employ genomic, proteomic, and AI/Machine Learning technologies to uncover valuable biological information about the patient’s disease.
Our dedicated laboratory team has the expertise to extract the DNA and RNA from clinical samples and perform state of the art molecular analysis. We leverage cutting-edge, ultra-sensitive technologies to deliver in-depth genomic diagnostic insights.
DNA or RNA, we have the right technologies to properly and holistically scrutinize any molecular biomarker. Whether you’re interested in a single variant or multiple genes, we can develop a sensitive and specific assay that is both high throughput and capable of rapid turnaround time.
We leverage cutting-edge, ultra-sensitive technologies to deliver in-depth genomic diagnostic insights.
As a pioneering market leader, we boast over 15 years of expertise in clinical proteomics. Proteomics are a powerful tool for understanding and predicting a patient’s response to disease and therapy. Whether you’re interested in quantifying single peptides, assessing post-translational modifications, or identifying a more complex proteomic signature we have the required tools, expertise and certified partners.
We leverage sensitive and both targeted and non-targeted technologies to deliver in-depth proteomic insights.
DNA or RNA, we have the right technologies to properly and wholistically scrutinize any molecular biomarker. Whether you’re interested in a single variant or multiple genes, we can develop a sensitive and specific assay that is both high throughput and capable of rapid turnaround time.
We leverage cutting-edge, ultra-sensitive technologies to deliver in-depth genomic diagnostic insights.
As a pioneering market leader, we boast over 15 years of expertise in clinical proteomics. Proteomics are a powerful tool for understanding and predicting a patient’s response to disease and therapy. Whether you’re interested in quantifying single peptides, assessing post-translational modifications, or identifying a more complex proteomic signature we have the required tools, expertise and certified partners.
We leverage sensitive and both targeted and non-targeted technologies to deliver in-depth proteomic insights.
Our extensively validated deep learning platform is optimized for the discovery of clinical diagnostic tests from multiple technologies, including genomics, transcriptomics, proteomics, and radiomics.